carbazilquinone has been researched along with Leukemia, Myeloid, Acute in 2 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higuchi, T | 1 |
| Okada, S | 1 |
| Mori, H | 1 |
| Niikura, H | 1 |
| Omine, M | 1 |
| Terada, H | 1 |
| Tabata, M | 1 |
| Imagawa, S | 1 |
| Tarumoto, T | 1 |
| Ohmine, K | 1 |
| Hatake, K | 1 |
| Miura, Y | 1 |
| Ozawa, K | 1 |
2 other studies available for carbazilquinone and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Leukemic transformation of polycythemia vera and essential thrombocythemia possibly associated with an alkylating agent.
Topics: Adult; Aged; Carbazilquinone; Chromosome Aberrations; Female; Follow-Up Studies; Humans; Leukemia, M | 1995 |
Essential thrombocythemia transformed to acute myelogenous leukemia with t(3;17)(p24; q12), del(5)(q13q34) after treatment with carboquone and hydroxyurea.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Carbazilquinone; Chromosomes, Human, P | 2000 |